INT279382

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.14
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 1.22
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell adhesion (Cd22) plasma membrane (Cd22)
Cd22 (Mus musculus)
Pain Link Frequency Relevance Heat
methotrexate 3 5.00 Very Low Very Low Very Low
vincristine 3 5.00 Very Low Very Low Very Low
dexamethasone 3 5.00 Very Low Very Low Very Low
palliative 1 5.00 Very Low Very Low Very Low
Central nervous system 1 5.00 Very Low Very Low Very Low
headache 1 5.00 Very Low Very Low Very Low
intrathecal 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Lymphatic System Cancer 82 94.72 High High
Chronic Lymphoid Leukemia 14 89.32 High High
Multiple Myeloma 8 72.80 Quite High
Acquired Immune Deficiency Syndrome Or Hiv Infection 4 68.40 Quite High
Htlv Types I And Ii 5 68.20 Quite High
Disease 39 68.00 Quite High
Mantle-cell Lymphoma 13 58.44 Quite High
Follicular Lymphoma 13 57.40 Quite High
Cancer 13 46.76 Quite Low
Infection 14 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Antibodies targeting CD19, CD20, CD22, in combination with a toxin, CD23, CD40, CD80, and HLA-DR are being evaluated in clinical trials, and their additional benefit will be evaluated in coming years (DiJoseph et al 2004, 2006; Byrd et al 2005; Czuczman et al 2005; Foreno-Torres et al 2006).
Regulation (targeting) of CD22
1) Confidence 0.14 Published 2008 Journal Biologics : Targets & Therapy Section Body Doc Link PMC2727901 Disease Relevance 1.22 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox